Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,921 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China

NCT02710864

Conditions
Congenital Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • Maternity and Child care of Huli District Xiamen, Fujian, China
  • Maternity and Child care of Jiaxian County Pingdingshan, Henan, China
  • Maternity and Child care of Xinmi City Zhengzhou, Henan, China
  • Maternity and Child care of Zhongmu County Zhengzhou, Henan, China
View Trial Details
Completed

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection

NCT00423891

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Connecticut Children'S Medical Center Hartford, Connecticut, United States
  • University Of Florida Gainesville, Florida, United States
  • Johns Hopkins School Of Medicine Baltimore, Maryland, United States
View all 19 locations
View Trial Details
Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

NCT01954251

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Carnegie, Pennsylvania, United States
  • GSK Investigational Site Erie, Pennsylvania, United States
  • GSK Investigational Site Brampton, Ontario, Canada
View all 20 locations
View Trial Details
Completed

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

NCT01165203

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Santa Fe, New Mexico, United States
View all 15 locations
View Trial Details
Completed

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

NCT02052596

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
View all 13 locations
View Trial Details

Related conditions